Aetna
Aetna is a health insurance company owned by CVS Health, providing commercial health plans, Medicare Advantage, Medicaid, and dental coverage. As part of CVS Health's vertically integrated ecosystem — which includes CVS Caremark (PBM), CVS Pharmacy, MinuteClinic, Oak Street Health, and Signify Health — Aetna operates within one of the most deeply integrated insurer-pharmacy-provider conglomerates in the United States.
Score generated by AI agents based on publicly cited evidence and reviewed by the project maintainer. Not independently validated. Last assessed 2026-09-25. Score revised 2026-09-25: 69 → 63.
Score History
Timeline events are AI-curated from public reporting. Score trajectory is derived from documented events.
Before the U.S. Healthcare acquisition, Aetna's health business was a traditional indemnity insurer that paid claims promptly and with little question and offered broad provider choice. The main blemish in the record is a 1993 settlement: two subsidiaries paid $5.2 million, on top of about $9.5 million in restitution, over secret payments to a Boston broker who advised public retirement systems. Employer-sponsored coverage created the lock-in standard for the industry, but managed-care tactics had not yet arrived.
The $8.9 billion U.S. Healthcare acquisition turned Aetna into the largest managed-care company, and the $1 billion Prudential HealthCare deal, which the DOJ and Texas sued to block, took membership to 21 million. Aetna adopted network restrictions, utilization review and payment controls. The Wall Street Journal documented the backlash in 1998, and Texas regulators settled charges over incentives that paid physicians to limit care. Physicians' RICO class action accused Aetna and other insurers of downcoding and delaying payments. CEO John Rowe responded by shedding 8 million members and about 15,000 jobs.
The $470 million RICO settlement forced changes in business practice: simpler claims, transparent reimbursement policies and firm payment deadlines. Aetna returned to profit as a pure health insurer, and under Ron Williams (CEO from 2006) revenue grew 54% from 2005 to 2009. Aetna priced out-of-network care with the Ingenix database, which allegedly understated fair payments, until a 2009 New York AG settlement. In late 2009 it repriced plans to push 600,000-650,000 members off its books to protect margins. Williams received $72 million in his final year.
Mark Bertolini became CEO on November 29, 2010, as the ACA reshaped the market. Aetna paid $120 million to settle the Ingenix underpayment class action and settled a Massachusetts AG case over deceptively marketed student coverage. It bought Coventry for $7.3 billion to expand in Medicare Advantage and Medicaid. In 2015 it raised its minimum wage from $12 to $16 and agreed to buy Humana for $37 billion. Practices later exposed in court date from this period: a medical director deciding cases without reading records (2012-2015), and a 2014 proton-therapy denial.
In July 2016 Bertolini warned the DOJ that Aetna would shrink its ACA exchange footprint if the government challenged the Humana deal. A federal judge blocked the $37 billion merger in January 2017, finding the exchange exits were meant to improve Aetna's litigation position, and Aetna left the exchanges entirely for 2018. The period also brought the HIV-status mailing breach, a medical director's admission that he never reviewed patient records, and a $25.5 million Oklahoma jury verdict over a proton-therapy denial. CVS announced its $69 billion purchase of Aetna in December 2017.
CVS closed its $69 billion purchase of Aetna with only a Part D divestiture to WellCare. It then built an insurer-PBM-pharmacy-clinic stack through HealthHUBs, the Aetna Connected steering plan, and the $8 billion Signify Health and $10.6 billion Oak Street Health deals. The conduct exposed later happened in this period. Post-acute prior authorization expanded 57.5% from 2019 to 2022 with a 25.9% denial rate, and projected savings from a denial initiative were revised to $77.3 million. Aetna also submitted unsupported diagnosis codes, the DOJ alleges it paid broker kickbacks from 2016 to 2021, and Caremark charged independent pharmacies DIR fees.
The Senate's 'Refusal of Recovery' report and Karen Lynch's exit as CEO on October 17, 2024 began a margin-first turnaround under David Joyner, the month CVS announced 2,900 layoffs. Aetna left the ACA exchanges for 2026 (about 1 million members), dropped Medicare Advantage in 100 counties, trimmed benefits, and imposed a lower 'level of severity' inpatient payment on hospitals. Legal consequences followed: a $117.7 million False Claims Act settlement, a DOJ kickback suit and an AI-focused securities suit that both survived dismissal, and an FTC settlement limiting Caremark. Aetna cut and sped up prior authorization, and by mid-2026 CVS's quarterly net income had tripled.
Alternatives
An integrated insurer-provider model whose average claim denial rate on ACA marketplace plans (about 8%) is well below the 18% national average, and whose Medicare Advantage plans average higher CMS star ratings than Aetna's, per MoneyGeek's 2026 comparison. Since Aetna left the ACA exchanges for 2026, Kaiser is a direct option for individual-market shoppers in its area. The catch: Kaiser operates only in 8 states and D.C., you generally must use Kaiser's own doctors and hospitals, and in January 2026 it paid a record $556 million, without admitting liability, to settle allegations that it inflated Medicare Advantage diagnoses, much like the coding claims Aetna settled.
For Aetna Medicare Advantage enrollees: traditional fee-for-service Medicare paired with a Medigap supplemental policy lets you see any provider that accepts Medicare nationwide and involves far less prior authorization than Medicare Advantage, though a CMS pilot that began in 2026 adds AI-assisted prior authorization for 17 services in six states. Moderate switch: you can leave Medicare Advantage only during enrollment windows, and outside your initial Medigap enrollment period or a guaranteed-issue situation, insurers in most states can charge more or refuse coverage based on your health. Premiums are generally higher than for Medicare Advantage.
Dimensional Breakdown
Summaries below were written by AI agents based on the cited evidence. They are editorial interpretations, not independent research findings.
Dimension History
Timeline (70 events)
Aetna subsidiaries pay $14.7 million over secret broker payments
Two Aetna subsidiaries agreed to pay $5.2 million to settle allegations that they had made secret payments to a Boston broker who advised local retirement systems in Massachusetts and Rhode Island on their purchase of financial services. The settlement came on top of approximately $9.5 million in restitution the subsidiaries had already paid to the affected retirement systems. The case established a pattern of undisclosed financial arrangements that would recur throughout Aetna's history.
Aetna acquires U.S. Healthcare for $8.9 billion
Aetna paid $8.9 billion for HMO provider U.S. Healthcare, transforming itself from a traditional indemnity insurer into the nation's largest managed healthcare provider. U.S. Healthcare founder Leonard Abramson received $929 million for his 10.8% stake, plus about $67 million under consulting and non-compete agreements and a U.S. Healthcare jet with a market value of about $25 million, according to SEC filings reported by The Morning Call. The deal introduced aggressive managed care tactics including network restrictions, utilization review, and physician payment controls that would define Aetna's next decade.
Aetna U.S. Healthcare HMOs run on PCP referrals and capitation
Aetna's first annual report after the U.S. Healthcare merger described the combined HMO model: each enrollee selects a primary care physician who is generally responsible for coordinating other care, including referrals to network specialists. Primary care physicians were paid principally by capitation, a fixed monthly fee per member regardless of the services provided, and the HMOs also used fixed-fee capitated arrangements for most mental health, substance abuse, laboratory and radiology services and generally required precertification of elective hospital admissions. HMO membership was 3.1 million at the end of 1996.
Wall Street Journal exposes Aetna managed care backlash
The Wall Street Journal published a front-page story on July 29, 1998 headlined 'Old-Line Aetna Adopts Managed-Care Tactics and Stirs a Backlash,' reporting that Aetna, which once paid claims promptly and with little question, was now prone to mishandling charges, paid far less for the same services, and sometimes kept doctors waiting months to settle bills. The article reported that hundreds of doctors had dropped out of Aetna's networks in the ensuing backlash.
DOJ and Texas AG sue to block Prudential HealthCare acquisition
The Department of Justice and Texas Attorney General filed a civil antitrust suit to block Aetna's proposed acquisition of Prudential's health care business, alleging the deal would harm competition in Houston and Dallas-Fort Worth. A consent decree allowed the acquisition to proceed after Aetna divested its NYLCare HMO businesses in those Texas markets.
Aetna acquires Prudential HealthCare for $1 billion
Aetna completed its $1 billion acquisition of Prudential's health care unit, becoming the nation's largest health insurer with 21 million members. Physician groups had opposed the deal, and Aetna had to divest HMO operations in Texas to win Justice Department approval. The acquisition compounded integration problems from the U.S. Healthcare deal, and the Prudential health unit turned out to be losing more money than anticipated.
Texas regulators settle charges over physician financial incentives and coverage failures
Aetna U.S. Healthcare settled accusations by Texas regulators that it provided improper financial incentives to physicians to limit patient care. The settlement required the establishment of an ombudsman's office to advocate for patients in coverage disputes. Separately, Aetna U.S. Healthcare paid $21,400 to the North Carolina Department of Insurance for various state rule violations. The settlements revealed how Aetna's managed care model created deceptive structures where patients believed they were receiving physician-directed care while doctors faced financial pressure to restrict services. The employer-sponsored coverage model left members unable to switch insurers outside annual open enrollment windows even when they discovered these limitations.
Aetna divests financial services to ING for $7.7 billion
Aetna sold its financial services and international businesses to Dutch insurer ING Group for $7.7 billion ($5 billion in cash plus $2.7 billion in assumed debt). The divestiture allowed Aetna to become a pure-play health company, but reflected the dire state of the health business. Profits had fallen from $901 million in 1997 to $716.9 million in 1999, with mounting losses from the failed integrations of U.S. Healthcare and Prudential.
John Rowe begins turnaround with massive membership cuts
New CEO Dr. John Rowe, the first trained physician to lead a major HMO, initiated a radical turnaround by prioritizing profitability over scale. Aetna shed 8 million covered lives (from 21 million to 13 million members), eliminated approximately 15,000 jobs, and dropped unprofitable employer accounts. The company posted losses of more than $265 million in 2001 before returning to profitability by 2003.
Physicians' amended RICO class action accuses Aetna and other insurers of payment conspiracy
Physicians filed an amended federal class-action complaint in Florida alleging a conspiracy among managed care organizations including Aetna, Cigna and Humana to 'deny, delay and diminish' payments to healthcare providers. Consolidating a suit the California Medical Association began in 2000 with suits from individual physicians and joined by the Texas and Georgia medical associations, the complaint invoked the Racketeer Influenced and Corrupt Organizations (RICO) Act and accused insurers of changing billing codes to reflect less expensive treatments, refusing payment based on arbitrary standards, and tying up claims while earning interest on withheld funds.
Aetna settles physician RICO class action for $470 million
Aetna and 20 medical societies representing over 700,000 physicians reached a $470 million settlement in the national managed care RICO class action. The settlement included $100 million in direct payments to physicians, approximately $300 million in business practice improvements (simplifying claims, transparent reimbursement policies, firm payment deadlines), $20 million for a health foundation, and up to $50 million in legal fees. U.S. District Judge Federico Moreno approved the settlement in October 2003.
Aetna acquires ActiveHealth Management for $400 million
Aetna purchased ActiveHealth Management for $400 million, its largest acquisition in nearly six years. ActiveHealth's patented CareEngine system applied evidence-based clinical rules to aggregated patient claims, laboratory, and pharmacy data, generating automated 'Care Considerations' that flagged treatment patterns. While marketed as quality improvement, the technology provided Aetna with sophisticated tools for algorithmic claims analysis and utilization management at scale. The acquisition expanded Aetna's technology-driven approach to managing healthcare costs, positioning the insurer as a health information technology company as well as a payer.
Ronald Williams becomes CEO, revenue grows 54%
Ronald Williams, who joined Aetna in 2001 as the main architect of its restructuring, succeeded John Rowe as CEO in February 2006. From 2005 to 2009, Aetna's revenues grew 54% to $34.7 billion and health plan membership grew 28% to 18.9 million. Williams received $72 million in total compensation in his final year (2010), including $50.4 million from exercising stock options granted in 2001, while Aetna shares fell from $51.30 on the day he became CEO to $30.16 when he stepped down in November 2010.
Aetna CEO announces premium hikes to force 650,000 members off coverage
CEO Ron Williams told analysts that Aetna would increase prices in 2010 and force 600,000 to 650,000 customers to drop their coverage. Williams stated that 'the pricing we put in place for 2009 turned out to not really be what we needed to achieve the results and margins that we had historically been delivering.' President Mark Bertolini explained the company had 'implemented a combination of underwriting enhancements, pricing actions and plan design changes, intended to ensure that each customer is priced to an appropriate margin.' The strategy prioritized shareholder margins over member retention, with members locked into annual enrollment cycles unable to switch plans mid-year.
Mark Bertolini becomes Aetna CEO as Williams steps back
Aetna announced on October 20, 2010 that Chairman and CEO Ronald Williams would retire in April 2011 and that president Mark Bertolini, head of business operations, would become chief executive officer effective November 29, 2010, with Williams serving as executive chairman in the interim. Bertolini had joined Aetna in 2003 from Cigna and NYLCare and was named president in July 2007.
Massachusetts AG fines Aetna $1 million for deceptive marketing and missing coverage
The Massachusetts Attorney General settled charges that Aetna failed to cover state-mandated health insurance benefits and deceptively marketed coverage to college students. Aetna had provided insurance to an average of 30,000 students per year between 2007 and 2010, with marketing materials falsely claiming the aggregate maximum coverage was $500,000 when it was actually $50,000. Aetna did not cover health services required by state law, including mental health care, pap test screening, mammography, and preventive care for children. The company paid at least $500,000 to reimburse consumers, $500,000 in civil penalties, and $55,000 for investigation costs.
Aetna acquires Coventry Health Care for $7.3 billion
Aetna announced the acquisition of Coventry Health Care for $7.3 billion (including assumed debt), expanding its Medicare Advantage and Medicaid managed care business. When the deal closed in May 2013, Aetna added approximately 3.7 million medical members and 1.5 million Medicare Part D members, and its Medicaid business grew from 1.1 million to more than 2 million members.
Aetna pays $120 million to settle Ingenix out-of-network underpayment suit
Aetna agreed to a $120 million settlement of a 2009 class action by psychologists, other providers and patients alleging it used the flawed Ingenix database, which consistently understated 'usual, customary and reasonable' rates, to underpay out-of-network claims. Aetna and other insurers had agreed to stop using Ingenix under 2009 settlements with the New York Attorney General.
Aetna moves 65% of its ad spend to digital as ACA exchanges open
Aetna's head of media told Beet.TV that, with the Affordable Care Act, the insurer had focused its advertising on education and information targeting key demographics, and that 65 percent of its advertising spend was now going to digital media, with at least 10 percent of the total going to programmatic video.
Bertolini raises Aetna minimum wage from $12 to $16
CEO Mark Bertolini announced raising Aetna's minimum wage from $12 to $16 per hour, providing an average 11% pay increase for 5,700 employees, with some seeing increases of 33%. Bertolini, who had adopted yoga and meditation after a debilitating ski accident, stated: 'Here we are a Fortune 50 company and we are about to put these people into poverty.' The move was unusual for the health insurance industry and briefly positioned Aetna as a labor governance leader.
Aetna announces $37 billion deal to acquire Humana
Aetna announced a $37 billion cash-and-stock agreement to acquire rival Humana, a deal Reuters said would bring Aetna close to Anthem's No. 2 spot by membership and nearly triple its Medicare Advantage business. The deal faced antitrust scrutiny and was blocked by a federal judge in January 2017.
Aetna threatens ACA exit to pressure DOJ on Humana merger
In a July 5 letter to the DOJ, Aetna CEO Mark Bertolini warned the company would immediately reduce its 2017 ACA exchange footprint if the DOJ sued to block its $37 billion acquisition of Humana. When the DOJ proceeded with the antitrust suit on July 21, Aetna announced in August it would exit 11 states' exchanges, forcing hundreds of thousands of members to find new coverage. A federal judge later determined the exit was 'for the purpose of improving its litigation position' rather than purely financial, noting Aetna abandoned even profitable exchange markets like Florida.
Federal judge blocks Aetna-Humana $37 billion merger
U.S. District Judge John Bates ruled that the proposed $37 billion Aetna-Humana merger would substantially lessen competition in Medicare Advantage plans across 364 counties. The decision came after a 13-day trial in December 2016. Aetna paid Humana a $1 billion termination fee. The judge's opinion noted that Aetna's ACA exit strategy constituted gamesmanship that undermined its credibility in antitrust arguments.
Aetna HIV medication mailing breach exposes 12,000 members
A vendor for Aetna sent letters to approximately 12,000 members using envelopes with oversized transparent windows that revealed the recipients were taking HIV medication. The mailing exposed the HIV status of nearly 12,000 individuals across multiple states. Aetna settled a class action lawsuit for $17 million in January 2018, paid $935,000 to California's attorney general, and accumulated an additional $640,000 in civil penalties across New Jersey, Connecticut, and Washington D.C.
CVS Health announces $69 billion acquisition of Aetna
CVS Health and Aetna announced a definitive merger agreement valued at approximately $69 billion ($78 billion including assumed debt). Under the terms, each Aetna share was exchanged for $145.00 in cash and 0.8378 CVS shares, valuing Aetna at approximately $212 per share. The deal would create the most vertically integrated healthcare conglomerate in U.S. history, combining the nation's largest pharmacy chain, a top-3 PBM, and a major health insurer.
Aetna medical director admits never reviewing patient records
CNN reported that former Aetna medical director Dr. Jay Ken Iinuma admitted under oath in an October 2016 deposition that he never looked at patients' medical records when deciding whether to approve or deny coverage. Iinuma served as medical director for Southern California from 2012 to 2015 and said he was following Aetna's training, in which nurses reviewed records and made recommendations. California's insurance commissioner launched an investigation, with three more states (Colorado, Washington, Connecticut) following. Aetna settled the underlying lawsuit in March 2019.
Oklahoma jury awards $25.5 million over Aetna proton therapy denial
An Oklahoma jury awarded $15.5 million in emotional distress damages and $10 million in punitive damages to the family of Orrana Cunningham, whom Aetna denied proton beam therapy for stage 4 nasopharyngeal cancer in 2014 by calling it investigational and experimental. Jurors said Aetna acted recklessly and meant the verdict as a message for Aetna to change its ways; an observer called it the largest individual bad-faith insurance verdict in Oklahoma history.
CVS Health completes $69 billion acquisition of Aetna
CVS Health completed its acquisition of Aetna after receiving regulatory approvals, with the DOJ requiring only a divestiture of Aetna's standalone Medicare Part D plans (approximately 2.2 million members) to WellCare. The minimal antitrust remedy, given the massive vertical integration scope, established CVS Health as the nation's most integrated healthcare conglomerate: insurer (Aetna), PBM (CVS Caremark), pharmacy (CVS), and clinic (MinuteClinic).
Massachusetts AG settles ghost network investigation with Aetna
Aetna settled with the Massachusetts Attorney General over allegations of inaccurate and deceptive provider directories, inadequate behavioral health networks, and unfairly denying or impeding coverage for substance use disorder treatment. Aetna agreed to pay $75,000, to maintain accurate directories and an adequate behavioral health network, to conduct monthly audits of its behavioral health provider directory and quarterly provider outreach, and to track member complaints about network adequacy.
New York regulators fine Aetna $1.95 million for consumer protection violations
The New York Department of Financial Services fined Aetna $1.95 million after a market conduct examination found that from 2012 through 2015 Aetna missed deadlines for making pre-authorizations, failed to acknowledge and respond to member complaints on time, failed to acknowledge receipt of members' grievances, and inappropriately applied cost sharing to and denied some preventive care claims. Earlier, in 2010, the New York Insurance Department had fined Aetna $850,000 for incomplete disclosures in explanation-of-benefits forms, and in 2009 the Arizona Department of Insurance had issued two fines totaling $256,500.
CVS pharmacy workers report dangerous understaffing and prescription errors
Pharmacy workers across CVS locations reported dangerous understaffing. The Oklahoma Board of Pharmacy inspected four CVS pharmacies from mid-2019 to early 2020 after multiple complaints and fined CVS $125,000. At one Bartlesville store inspectors found a 6% error rate, including the wrong dose of an antibiotic for a 1-year-old, and described a chaotic scene; an audit found an error rate of about 22% (66 errors out of 305 prescriptions). CVS agreed to remind Oklahoma pharmacists they would not face retaliation for reporting unsafe working conditions.
CVS launches HealthHUB integration with Aetna plans
CVS Health began rolling out HealthHUB locations that expanded MinuteClinic-style services to include blood draws, enhanced screenings, and chronic disease management. CVS announced plans to open 1,500 HealthHUBs by the end of 2021, choosing initial markets based on Aetna members' chronic-disease data, and analysts predicted Aetna's 22 million members would be guided to HealthHUBs for chronic care.
California DMHC finds Aetna improperly denied emergency room claims since 2010
The California Department of Managed Health Care found that Aetna applied its national 'prudent layperson' standard to deny coverage for emergency medical services, violating California's more protective emergency care coverage requirements. Aetna acknowledged the practice dated back to at least 2010 but continued denying ER claims even after entering settlement agreements with DMHC in 2015 ($10,000 penalty) and 2016 ($125,000 penalty). A 2019 survey found 93% of sampled claims were wrongfully denied. The DMHC eventually imposed a $500,000 fine in 2020, ordering Aetna to re-adjudicate all emergency claims denied since February 2017.
Aetna Connected plan steers members to CVS clinics and pharmacies
Aetna rolled out Aetna Connected, a plan design for employers in the Kansas City market giving members no-copay visits at CVS MinuteClinics and HealthHUBs plus free prescription delivery, with CVS expecting additional front-store revenue. Former FTC policy director David Balto warned it would likely mean less choice and higher costs, calling it an approach where members have many choices 'as long as they're CVS.'
OCR fines Aetna $1 million for three 2017 HIPAA breaches
The HHS Office for Civil Rights announced a $1 million settlement with Aetna for three 2017 data breaches: online exposure of 5,002 members' PHI through unsecured web services, the HIV medication mailing that affected nearly 12,000 individuals, and a mailing error that revealed atrial fibrillation study participants' conditions to 1,600 members. OCR found Aetna failed to perform required security evaluations, verify entity identity for PHI access, and implement minimum necessary disclosure safeguards.
CVS says Aetna will return to the ACA exchanges for 2022
On its first earnings call as CVS Health CEO, former Aetna president Karen Lynch said Aetna would target January 1, 2022 to re-enter the ACA exchanges, which it had fully exited in 2018 after heavy losses, citing a stabilized individual market.
CVS Health donates $5 million to dark money group opposing Medicare expansion
The Intercept reported that CVS Health provided $5 million to the Partnership for America's Health Care Future (PAHCF), a dark money group formed in 2018 to lobby against Medicare for All, the public option, and other proposals to expand public coverage. The donation came during the COVID-19 pandemic that had killed hundreds of thousands, while millions lost employer-sponsored coverage. CVS also donated $1.75 million each to Majority Forward and One Nation, Senate-linked groups on both sides of the aisle.
FTC launches investigation into CVS Caremark and major PBMs
The Federal Trade Commission ordered the six largest pharmacy benefit managers, including CVS Caremark, to turn over five years of information on their business practices. The inquiry covered fees and clawbacks charged to unaffiliated pharmacies, methods of steering patients to PBM-owned pharmacies, prior authorization and other administrative restrictions, and the effect of manufacturer rebates and fees on formulary design.
CVS agrees to $5 billion opioid settlement
CVS Health agreed to pay approximately $5 billion ($4.9 billion to state and local governments and about $130 million to tribes) over ten years to settle lawsuits alleging it filled inappropriate opioid prescriptions. CVS and Walgreens announced their deals the same day, the first nationwide opioid resolutions with pharmacy chains, and CVS admitted no liability or wrongdoing.
CVS acquires Signify Health for $8 billion
CVS Health completed its $8 billion acquisition of Signify Health, a home health and technology company that conducts in-home health evaluations for Medicare Advantage members. These evaluations support risk adjustment coding, which determines how much CMS pays insurers per member. Adding Signify to the CVS-Aetna ecosystem created a new revenue layer: Aetna insures the member, Signify evaluates them at home to generate higher risk-adjustment payments, and the member is steered to CVS-owned care settings.
CVS acquires Oak Street Health for $10.6 billion
CVS Health completed its $10.6 billion acquisition of Oak Street Health, gaining approximately 169 primary care medical centers in 21 states serving predominantly Medicare patients. Combined with the Signify Health purchase weeks earlier, CVS spent $18.6 billion deepening its vertical integration into primary care and home health. CVS expected $500 million in synergies and planned to become the 'premier multi-payer Medicare value-based care platform.'
Kraft Heinz sues Aetna alleging fiduciary breach in handling $1.3 billion in plan claims
Kraft Heinz's employee benefits group filed a lawsuit accusing Aetna of breaching ERISA fiduciary duties as a third-party administrator. The lawsuit alleged Aetna took more than $1.3 billion from the group and pursued claims processing practices that harmed the company while pocketing millions in undisclosed fees, paying duplicate claims without follow-up, and providing incomplete data when Kraft Heinz tried to retrieve its claims records. The case was moved to arbitration.
Independent pharmacies file DIR fees class action against CVS
Attorneys filed a class action lawsuit against CVS Health, Caremark, and Aetna on behalf of independent pharmacies to recoup DIR (Direct and Indirect Remuneration) fees on Medicare Part D prescriptions. The suit claims Caremark assessed pharmacy DIR fees in violation of federal antitrust laws and state contract laws, and challenges Caremark's arbitration agreements as unfair and unenforceable. NCPA noted that DIR fees had risen by more than 107,400% in recent years.
OIG finds Aetna Medicare Advantage plan received $25.5 million in overpayments
The HHS Office of Inspector General found that most diagnosis codes Aetna submitted to CMS for its Medicare Advantage risk adjustment program did not comply with federal requirements. Of 210 sampled enrollee-years, 155 had medical records that did not support the submitted diagnosis codes. The estimated overpayments totaled $25.5 million for 2015 and 2016 alone. Aetna argued the OIG's methodology was flawed by expecting 'perfect coding.'
NY AG exposes ghost networks across 13 health plans including Aetna
The New York Attorney General's investigation of 13 health plans found that 86% of listed mental health providers were not actually available to patients. The study tested provider directories by calling listed providers and found the vast majority were not accepting new patients, not at the listed location, not in-network, or unreachable. The findings demonstrated that health plans including Aetna use inflated directories to attract members while failing to maintain adequate behavioral health networks.
Aetna settles LGBTQ+ fertility coverage discrimination for $2 million
Aetna agreed to settle a class action lawsuit accusing the insurer of discriminating against LGBTQ+ customers needing fertility treatment. The settlement required Aetna to make coverage of artificial insemination standard for all customers nationally, regardless of sexual orientation. The case alleged Aetna's coverage policies required a clinical infertility diagnosis that effectively excluded same-sex couples and single individuals from fertility benefits.
Senate investigation finds CVS used cost-driven algorithms to deny post-acute care
The Senate Permanent Subcommittee on Investigations released its report 'Refusal of Recovery,' finding that UnitedHealthcare, Humana and CVS used prior authorization and algorithmic tools to deny post-acute care to boost profits. CVS's 'Post-Acute Analytics' initiative was initially projected to save $10-15 million over three years before CVS revised the projection to $77.3 million months later. The number of CVS/Aetna post-acute care requests subject to prior authorization increased 57.5% between 2019 and 2022, while Aetna's post-acute denial rate (25.9%) remained the highest of the three insurers.
CVS CEO Karen Lynch ousted; 2,900 jobs cut in cost-cutting initiative
CVS Health CEO Karen Lynch stepped down on October 17, replaced by Caremark head David Joyner, as CVS warned that third-quarter adjusted EPS would be $1.05-1.10 versus analyst estimates of $1.69. Aetna president Brian Kane had left about a year after his arrival, with Lynch taking over the insurance segment in August. Earlier in October, CVS had announced 2,900 layoffs as part of a $2 billion cost-cutting initiative. Lynch received $23.4 million in 2024 compensation and Joyner $17.8 million.
CVS pharmacy workers stage three-day strike at seven Southern California stores
CVS pharmacy workers at seven stores in Los Angeles and Orange County staged a three-day unfair labor practice strike after months of stalled contract talks covering more than 7,000 California pharmacy workers. UFCW alleged CVS engaged in unlawful surveillance of workers and retaliation for union activity. Days later the unions reached a tentative agreement, ratified in November as a three-year contract with wage increases, more secure staffing levels, and a more affordable healthcare plan.
ProPublica exposes EviCore prior authorization outsourcing model
ProPublica published an investigation into EviCore, the third-party company used by insurers including Aetna to manage prior authorization decisions. EviCore marketed a 3-to-1 return on investment to insurers, meaning for every $1 spent on EviCore, the insurer paid $3 less on medical care. EviCore salespeople boasted of a 15% increase in denials, and large insurers sometimes requested 'high touch' plans that sent more cases to manual review to increase denial rates. EviCore covers approximately 100 million consumers.
DOJ sues CVS over opioid dispensing, citing pharmacist understaffing
Federal prosecutors unsealed a lawsuit alleging CVS unlawfully dispensed opioids and other controlled substances for more than a decade. The complaint cites hundreds of employee complaints of 'skeleton crews' and 'endless tasks' that executives ignored, and alleges pharmacists were pressured to fill prescriptions as fast as possible under staffing levels that made it impossible to meet both legal obligations and CVS's metrics.
Aetna announces exit from ACA exchanges for 2026
CVS Health announced that Aetna would exit the ACA individual exchange market in all states where it independently operates plans, effective 2026, after what CEO David Joyner called continued underperformance with no pathway to improve. CVS's Health Care Benefits segment had posted a $924 million adjusted operating loss in the third quarter of 2024, and Aetna had about 1 million exchange members. The exit marked Aetna's second retreat from the exchanges: it left in 2018 and returned for the 2022 plan year.
DOJ files Medicare Advantage kickback complaint against Aetna
The Department of Justice filed a False Claims Act complaint alleging Aetna, Humana, and Elevance Health paid hundreds of millions of dollars in illegal kickbacks to brokers eHealth, GoHealth, and SelectQuote between 2016 and 2021 to boost Medicare Advantage enrollment. The DOJ further alleged Aetna conspired with brokers to discriminate against Medicare beneficiaries with disabilities, threatening to withhold kickbacks to pressure brokers to enroll fewer disabled individuals perceived as less profitable.
HHS OIG finds CVS's Coventry plan upcoded Medicare Advantage diagnoses
An HHS Office of Inspector General audit found most diagnosis codes that CVS subsidiary Coventry Health and Life Insurance submitted to CMS for 2018-2019 were unsupported by medical records, producing almost $7 million in estimated overpayments. Coventry largely disagreed and refused the recommendation to refund the money and search for further noncompliance.
CVS texts Louisiana patients to fight PBM-pharmacy ownership bill
CVS sent a mass text to thousands of Louisiana pharmacy customers warning that pharmacies would close and drug prices rise if the state passed H.B. 358, which would have barred companies from operating both PBMs and pharmacies. In September 2025 House Oversight Chair James Comer and Rep. Clay Higgins wrote to CEO David Joyner that using patients' prescription contact data for political advocacy may have violated HIPAA; CVS said its conduct was lawful.
CVS Caremark hit with $289.9 million whistleblower judgment
A Pennsylvania federal judge entered a $289.9 million judgment against CVS Caremark in the Behnke whistleblower case, tripling the initial $95 million in damages after finding CVS's conduct was 'financially motivated.' Following a bench trial, the court found Caremark caused Part D plan sponsors, including Aetna, to submit inflated drug-cost claims to the federal government, holding it liable for two years of overbilling. CVS said it would appeal.
Aetna drops Medicare Advantage from 100 counties for 2026
CMS's 2026 plan data showed Aetna offering Medicare Advantage plans in one fewer state and 100 fewer counties as the largest carriers trimmed underperforming areas to recover margins. Analysts reported that Aetna, Elevance and UnitedHealthcare also materially cut over-the-counter allowances in non-special-needs plans.
CVS writes down Oak Street Health by $5.7 billion, closes 16 clinics
CVS recorded a $5.7 billion goodwill impairment on its health care delivery unit, pushing it to a $3.99 billion third-quarter loss, and said it would close 16 underperforming Oak Street Health clinics and slow new openings. Aetna's medical benefit ratio improved to 92.8% from 95.2% a year earlier as the insurance turnaround progressed.
Aetna sets 'level of severity' inpatient payment cut for January 2026
Aetna said its Medicare Advantage and dual-eligible 'level of severity' inpatient payment policy would take effect January 1, 2026 instead of November 15. Urgent stays of one to four midnights that fail MCG criteria will be paid at a lower rate Aetna describes as comparable to observation, set outside contract negotiations. The AHA had asked Aetna in September to rescind the policy.
House Judiciary report documents CVS Caremark anti-competitive practices
The House Judiciary Committee released a report titled 'When CVS Writes the Rules' documenting how CVS Caremark issued cease-and-desist letters to independent pharmacies working with competing digital 'hub' pharmacies, threatening network termination, after CVS developed its own competing hub services. The report notes that CVS Caremark's network covers about 30 percent of insured Americans, and that CVS owns the insurer (Aetna), the PBM (Caremark) and the pharmacy chain (CVS Pharmacy).
CVS lays off 313 more Aetna remote workers
CVS notified Connecticut officials it would lay off 313 remote workers in Aetna's small group business between April 3 and July 31, 2026. It was the seventh round of Aetna layoffs since October 2024, bringing the total to more than 1,000 in two years.
Pennsylvania fines Aetna $550,000 for mental health parity violations
A Pennsylvania Insurance Department market conduct exam covering October 2021 to December 2022 found parity violations, including incomplete claim files for autism services and denial letters that did not clearly explain why services were denied. Under a January 2026 consent order Aetna must pay a $550,000 penalty, reprocess affected claims with interest and fix its practices within 12 months.
Aetna pays $117.7 million over Medicare Advantage diagnosis coding
Aetna agreed to pay $117.7 million to resolve False Claims Act allegations that it submitted or failed to delete inaccurate diagnosis codes to raise Medicare Advantage payments: $106.2 million over a 2015 chart-review program that kept unsupported codes, and $11.5 million over morbid obesity codes from 2018-2023 raised by a former coding auditor. Aetna admitted no liability and refused a Corporate Integrity Agreement, so OIG reserved the right to exclude it.
Judge lets DOJ Medicare Advantage kickback suit against Aetna proceed
A federal court in Massachusetts ruled that Aetna, Elevance and Humana must face the government's False Claims Act suit alleging they paid online brokers kickbacks for Medicare Advantage enrollments and paid brokers to limit sign-ups of people with disabilities. The case began as a 2021 whistleblower suit that the DOJ joined; the insurers deny wrongdoing.
CVS proxy: CEO Joyner paid $21.2 million, 336 times median worker
CVS's 2026 proxy statement reported 2025 total compensation of $21.2 million for CEO David Joyner against $63,262 for the median employee, a 336-to-1 ratio. Joyner also became chair of the board on January 1, 2026, combining the roles, with a lead independent director retained.
Aetna reports faster, standardized prior authorizations
Aetna said it had standardized 88% of its prior authorization volume, approves more than 95% of eligible requests within 24 hours, processes 83% in real time, and launched bundled condition-specific reviews combining medical and pharmacy decisions, as part of the industry prior authorization pledge.
FTC settlement forces Caremark to change rebate and pharmacy practices
The FTC settled its insulin rebating case against CVS Caremark. The order requires Caremark to delink PBM fees from list prices, stop disfavoring low-list-price drugs on its formularies, offer plan sponsors point-of-sale rebate pass-through, give community pharmacies a cost-plus reimbursement option, and stop interfering with hub pharmacies. The FTC estimated up to $8.5 billion in consumer savings over 10 years.
CVS profits triple as Aetna cuts benefits and exits markets
CVS's second-quarter 2026 net income reached almost $3 billion, about triple a year earlier, as the Aetna segment doubled operating income and cut its medical loss ratio to 87.4%. Executives credited Medicare Advantage after the insurer cut benefits and exited unprofitable markets; Aetna ended the quarter with 26 million members, about 600,000 fewer than at the end of 2025.
Aetna stops paying brokers on 123 Medicare Advantage plans for 2027
Aetna told marketing organizations it would not pay commissions for new enrollments in 123 Medicare Advantage plans across 33 states, covering nearly 780 counties, for the 2027 plan year, nor for new standalone Part D enrollments. Existing members keep their plans, but brokers have no incentive to present the frozen plans, which disappear from the options seniors are shown without public notice.
Court lets CVS securities suit over AI-assisted prior authorization proceed
The Southern District of New York granted in part and denied in part CVS's motion to dismiss a securities class action, letting claims proceed that CVS failed to disclose the role AI-assisted prior authorization played in its cost savings and profitability. The court rejected claims that CVS's AI use violated Medicare rules and its 'responsible AI' statements. Discovery began, and CVS moved for reconsideration on September 10.
Evidence (61 citations)
D1: User Value Erosion
D2: Business Customer Exploitation
D3: Shareholder Extraction
D4: Lock-in & Switching Costs
D5: Twiddling & Algorithmic Opacity
D6: Dark Patterns
D7: Advertising & Monetization Pressure
D8: Competitive Conduct
D9: Labor & Governance
D10: Regulatory & Legal Posture
Scoring Log (9 entries)
Checked 2 alternatives. Kaiser: replaced unsourced denial/satisfaction comparison with MoneyGeek 2026 figures, updated for Aetna's 2026 ACA exit, added Kaiser's $556M MA upcoding settlement. Medigap: removed false claim that traditional Medicare eliminates prior auth/AI denials (CMS WISeR pilot), added medical-underwriting caveat.
Checked 11 removed/trimmed claims: 1 restored, 6 partly restored, 4 confirmed removed, 0 already present. Restored: MA AG 30-day directory fix (Boston Globe). Partly: Abramson consulting/non-compete ~$67M + ~$25M jet (Morning Call); 1996 10-K PCP referral/capitation model; 65% digital ad spend (Beet.TV); ~900,000-doctor RICO class (MDedge); Aetna already third-largest at Coventry close (Motley Fool); Texas 'danger to the public' letter (NYT) and Merlo $36.5M (Fierce); $12.6B 2021 pharmacy DIR (MedPAC). Confirmed removed: Williams '70% stock fall' (Courant: $51.30 to $30.16), WSJ 'catalyzed backlash', LeadingAge MA supplemental-benefit ads (industry-wide only), 'same members' revenue clause.
Checked 97 items + prose. 40 verified, 37 corrected (10 date-only), 14 re-sourced, 6 removed (1 wrong entity: UHC's $15.6M parity settlement; 2 duplicates; 3 unsupported composites). Invented: $10M consulting/$25M non-compete breakdown of Abramson payout; '70%' stock fall under Williams; '$12.6B' 2021 DIR fees. Also fixed: 'willfully disregarded' misattributed to Senate report, $924M loss mis-dated as full-year 2024, 57.5% scope, NY DFS fine year (2018 not 2013), ACA exit date (May 2025), $289.9M judgment date (Aug 2025), 7,000-worker strike (seven stores), DOJ opioid suit described as employee suit, dummy-codes class size (250,000+).
69->63. D1 7->6 (recalibration: denial and ghost-network facts date from 2019-2023; recent harms are exits and benefit cuts, partly offset by faster prior authorization; fits 6 not 7), D2 8->7 (event: FTC Caremark settlement July 2026 adds cost-plus and hub protections; DIR clawbacks ended 2024), D3 7->6 (recalibration: no buybacks since 2025 and layoffs coincided with Aetna losses, which fits 4-7 rather than record-profit extraction; profits via benefit cuts keep it at 6), D4 6->5 (recalibration: broad networks and voluntary CVS steering; Aetna's exits push members out and Oak Street is shrinking), D5 8->7 (correction: 'willfully disregarded' was the plaintiffs' wording, not the Senate's; the denial algorithm ran 2019-2023 and was scored 8 in that era; the $117.7M coding settlement keeps it at 7), D6 7->6 (correction: 86% ghost-network figure is aggregate across 13 plans and the MA-marketing claim lost its source). Eras: all 7 re-dated to real inflections: Pre-HMO 1996-01-01->1993-01-01; Managed Care Crisis 1998-07-01->1996-07-19 (U.S. Healthcare deal); Rowe Restructuring 2003-05-01->2003-05-22 (RICO settlement), relabeled 'Post-Settlement Recovery'; Bertolini 2012-01-01->2010-11-29 (CEO start); ACA Exit & Merger Gambit 2016-08-01->2016-07-05 (DOJ letter); CVS Vertical Integration 2020-01-01->2018-11-28 (merger close); final era 2026-02-16->2024-10-17 (Senate report and Lynch exit), relabeled 'Joyner Margin Recovery'. Every era re-scored; CVS integration era rises 57->65 as it now holds the 2019-2023 algorithm, upcoding and DIR period. Since Feb 2026: $117.7M FCA risk-adjustment settlement with CIA refused (Mar), PA parity fine (Mar), DOJ kickback suit survives dismissal (Mar), 313 more layoffs, FTC-Caremark settlement (Jul), CVS Q2 net income tripled on benefit cuts and exits (Aug), 2027 broker-commission freeze on 123 MA plans (Aug), AI prior-auth securities suit survives dismissal (Aug); level-of-severity inpatient payment cut in force from Jan 2026; Aetna reports faster prior authorization (Apr). Timeline[42] fixed (re-entry year).
Triaged 2026-06-29; no rescore warranted (no material change since baseline, or changes sub-threshold).
D1/D6: corrected 86% ghost network figure from Aetna-specific to aggregate across all 13 plans surveyed by NY AG. D2/D10: corrected $95M and $289.9M presented as separate cases — same Behnke whistleblower case, initial damages trebled. D3/D7: corrected revenue from '$357 billion' (2023 figure) to '$372.8 billion' (actual 2024). Fixed evidence: ghost network URLs now point to NY AG press release, $77.3M evidence URL now points to Healthcare Dive Senate report article, DOJ kickback date corrected from 2025-06-15 to 2025-05-01. History entry format corrected to match schema (score instead of overallScore, removed non-standard fields).